23andMe customers notified of bankruptcy and potential claims — deadline to file is July 14

23ndme, the giant test giant that was estimated at billions, is now moving in Chapter 11 of bankruptcy and notifying millions of current and previous customers that they may be eligible to submit claims as part of the restructuring process. The company and 11 of its subsidiaries, including Lemonaid Health and LPRXONE, have advanced to protect bankruptcy on March 23 this year in the eastern region of Missouri. The customers were alerted on Sunday that they have until July 14 to submit claims for the inconsistent losses.

The bankruptcy follows 18 months for 23ndme, characterized by low sales, executive departures and devastating violation of data that are subjected to sensitive personal information of about 7 million users. The violation, publicly disclosed in October 2023, revealed customer names, birth years, marks of relationships, common DNA ratios with relatives, asset reports, and self -reported sites, according to Techcrunch. The repercussions raised multiple collective lawsuits and a wave of customer ingredients that strongly undermine the work of the company facing the consumer.

Now, customers who have been affected by this breach – specifically those who were notified by 23andme that their information has been at risk between May and October 2023 – may provide what is known as the Cyber ​​Security incident. Those who have suffered from financial or other damage due to breach can make a claim as part of the bankruptcy issue. Customers who have other types of grievances are not associated with electronic attack, such as problems related to the results of DNA testing or remote services in the company, may provide a separate claim under the general tape date package.

congress also expressed concerns about the effects of privacy on bankruptcy.

The fall of Grace was 23ndme, and its problems were worsened by expanding the ambitious and infected with digital health and a distance doctor, which included the acquisition of the health of lemon of $ 400 million in 2021. It originally aims to diversify 23ndme offers beyond the DNA test for consumers, and the 23ndme movements are carried out with financial resources and failure to provide growth.

A proposed settlement of $ 30 million in a related collective lawsuit remains suspended due to bankruptcy procedures. (23ANDME Lawyers says that the settlement is now a dispute after the company is bankrupt.

Techcrunch reached 23andme for comment.